Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm

Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm

Item
http://www.wikidata.org/entity/Q34636002
Adjuvant therapy for renal cell carcinoma: past, present, and futureThe relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.Tissue slice grafts of human renal cell carcinoma: an authentic preclinical model with high engraftment rate and metastatic potential.Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: results from a proteomic study integrated with bioinformatics analysisProspective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma.RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma.Tivozanib in the treatment of renal cell carcinoma.Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.Potential biofluid markers and treatment targets for renal cell carcinoma.Novel tyrosine kinase inhibitors for renal cell carcinoma.Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.Emerging Role of MicroRNAs in mTOR Signaling.A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma.Cystic Duct Metastasis from Renal Cell Carcinoma.Synergistic antitumor responses by combined GITR activation and sunitinib in metastatic renal cell carcinoma.Is there a role for adjuvant therapy after surgery in “high risk for recurrence” kidney cancer? An update on current concepts
P2860

Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm

Item
http://www.wikidata.org/entity/Q34636002
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Novel therapies for metastatic ...... e VEGF/mTOR signaling paradigm
@ast
Novel therapies for metastatic ...... e VEGF/mTOR signaling paradigm
@en
Novel therapies for metastatic ...... e VEGF/mTOR signaling paradigm
@nl
type
label
Novel therapies for metastatic ...... e VEGF/mTOR signaling paradigm
@ast
Novel therapies for metastatic ...... e VEGF/mTOR signaling paradigm
@en
Novel therapies for metastatic ...... e VEGF/mTOR signaling paradigm
@nl
prefLabel
Novel therapies for metastatic ...... e VEGF/mTOR signaling paradigm
@ast
Novel therapies for metastatic ...... e VEGF/mTOR signaling paradigm
@en
Novel therapies for metastatic ...... e VEGF/mTOR signaling paradigm
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Novel therapies for metastatic ...... e VEGF/mTOR signaling paradigm
@en
P2093
P2860
P304
P31
P356
10.1158/1535-7163.MCT-11-0806
P433
P478
P577
P698
P932